Su-Ying Wu

ORCID

Publication Activity (10 Years)

Years Active: 2019-2021
Publications (10 Years): 6

Top Venues

Journal of medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Lung-Chun Lee, Yi-Hui Peng, Hsin-Huei Chang, Tsu Hsu, Cheng-Tai Lu, Chih-Hsiang Huang, Ching-Cheng Hsueh, Fang-Chun Kung, Ching-Chuan Kuo, Weir-Torn Jiaang, Su-Ying Wu
Xanthine Derivatives Reveal an Allosteric Binding Site in Methylenetetrahydrofolate Dehydrogenase 2 (MTHFD2). Journal of medicinal chemistry 64 (15) (2021)
Yi-Hui Peng, Fang-Yu Liao, Chen-Tso Tseng, Ramajayam Kuppusamy, An-Siou Li, Chi-Han Chen, Yu-Shiou Fan, Sing-Yi Wang, Mine-Hsine Wu, Ching-Cheng Hsueh, Jia-Yu Chang, Lung-Chun Lee, Chuan Shih, Kak-Shan Shia, Teng-Kuang Yeh, Ming-Shiu Hung, Ching-Chuan Kuo, Jen-Shin Song, Su-Ying Wu, Shau-Hua Ueng
Correction to Unique Sulfur-Aromatic Interactions Contribute to the Binding of Potent Imidazothiazole Indoleamine 2,3-Dioxygenase Inhibitors. Journal of medicinal chemistry 63 (13) (2020)
Yi-Hui Peng, Fang-Yu Liao, Chen-Tso Tseng, Ramajayam Kuppusamy, An-Siou Li, Chi-Han Chen, Yu-Shiou Fan, Sing-Yi Wang, Mine-Hsine Wu, Ching-Cheng Hsueh, Jia-Yu Chang, Lung-Chun Lee, Chuan Shih, Kak-Shan Shia, Teng-Kuang Yeh, Ming-Shiu Hung, Ching-Chuan Kuo, Jen-Shin Song, Su-Ying Wu, Shau-Hua Ueng
Unique Sulfur-Aromatic Interactions Contribute to the Binding of Potent Imidazothiazole Indoleamine 2,3-Dioxygenase Inhibitors. Journal of medicinal chemistry 63 (4) (2020)
Wen-Hsing Lin, Su-Ying Wu, Teng-Kuang Yeh, Chiung-Tong Chen, Jen-Shin Song, Hui-Yi Shiao, Ching-Chuan Kuo, Tsu Hsu, Cheng-Tai Lu, Pei-Chen Wang, Tsung-Sheng Wu, Yi-Hui Peng, Hui-You Lin, Ching-Ping Chen, Ya-Ling Weng, Fang-Chun Kung, Mine-Hsine Wu, Yu-Chieh Su, Kuo-Wei Huang, Ling-Hui Chou, Ching-Cheng Hsueh, Kuei-Jung Yen, Po-Chu Kuo, Chen-Lung Huang, Li-Tzong Chen, Chuan Shih, Hui-Jen Tsai, Weir-Torn Jiaang
Identification of a Multitargeted Tyrosine Kinase Inhibitor for the Treatment of Gastrointestinal Stromal Tumors and Acute Myeloid Leukemia. Journal of medicinal chemistry 62 (24) (2019)
Shu-Yu Lin, Yung Chang Hsu, Yi-Hui Peng, Yi-Yu Ke, Wen-Hsing Lin, Hsu-Yi Sun, Hui-Yi Shiao, Fu-Ming Kuo, Pei-Yi Chen, Tzu-Wen Lien, Chun-Hwa Chen, Chang-Ying Chu, Sing-Yi Wang, Kai-Chia Yeh, Ching-Ping Chen, Tsu-An Hsu, Su-Ying Wu, Teng-Kuang Yeh, Chiung-Tong Chen, Hsing-Pang Hsieh
Discovery of a Furanopyrimidine-Based Epidermal Growth Factor Receptor Inhibitor (DBPR112) as a Clinical Candidate for the Treatment of Non-Small Cell Lung Cancer. Journal of medicinal chemistry 62 (22) (2019)
Tsung-Sheng Wu, Wen-Hsing Lin, Hui-Jen Tsai, Ching-Cheng Hsueh, Tsu Hsu, Pei-Chen Wang, Hui-You Lin, Yi-Hui Peng, Cheng-Tai Lu, Lung-Chun Lee, Chih-Hsiang Tu, Fang-Chun Kung, Hui-Yi Shiao, Teng-Kuang Yeh, Jen-Shin Song, Jia-Yu Chang, Yu-Chieh Su, Li-Tzong Chen, Chiung-Tong Chen, Weir-Torn Jiaang, Su-Ying Wu
Discovery of Conformational Control Inhibitors Switching off the Activated c-KIT and Targeting a Broad Range of Clinically Relevant c-KIT Mutants. Journal of medicinal chemistry 62 (8) (2019)

Su-Ying Wu.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Su-Ying Wu